Is sulphadoxine-pyrimethamine (SP) still useful as the first-line antimalarial drug in Malawi or it must be quickly withdrawn from the antimalarial repertoire?

समान संसाधन

• Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa)
  द्वारा: Charle, Pilar, और अन्य
  प्रकाशित: (2009)
• Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran
  द्वारा: Zakeri, Sedigheh, और अन्य
  प्रकाशित: (2007)
• Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali
  द्वारा: Maiga, Hamma, और अन्य
  प्रकाशित: (2015)
• In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi
  द्वारा: Gutman, Julie, और अन्य
  प्रकाशित: (2015)
• Pyrimethamine-sulphadoxine: how great the risk?
  द्वारा: Stürchler, D
  प्रकाशित: (1990)